The Final Results of a Phase I Study Using Bortezomib (Velcade), Cladribine, and Rituximab (VCR) in Treating Mantle Cell Lymphoma Jeffrey J. Pu,Kristin Berger,Chunlei Zheng,Nhan V. Do,David F. Claxton,W. Christopher Ehmann,Joseph J. Drabick, Loughran P. Thomas,Elliot EpnerBLOOD(2023)引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要